Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Filana Therapeutics, Inc.

Filana Therapeutics, Inc. (FLNA) Stock Overview

Explore Filana Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

FLNA●NASDAQ
HealthcareBiotechnology
$0.73
$0.01(1.59%)
U.S. Market opens in 11h 52m

Filana Therapeutics, Inc. (FLNA)

Meyka AI Score

Z

Key Financials

Market Cap35.3M
P/E Ratio-0.83
EPS (TTM)$-0.87
ROE-0.59%
Fundamental Analysis

AI Price Forecasts

1 Month$-1.22
3 Months$0.32
1 Year Target$0.28

FLNA Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Filana Therapeutics, Inc. (NASDAQ: FLNA) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Filana Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of FLNA on the NASDAQ shows an RSI of 40.35, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.28 for the NASDAQ listing.

Key metrics behind Filana Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.83 and a market capitalization of 35.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of FLNA on the NASDAQ.

Price Performance (NASDAQ: FLNA)

1-Day Change
-1.59%
5-Day Change
-10.35%
1-Month Change
1.78%
3-Month Change
-32.88%
6-Month Change
-53.99%
Year-to-Date (YTD) Change
-64.31%
1-Year Change
-64.31%
3-Year Change
-64.31%
5-Year Change
-64.31%
All-Time (Max) Change
-64.31%

Contact Information

https://www.filanatx.com
512 501 2444
6801 N. Capital of Texas Highway, Austin, TX, 78731

Company Facts

190 Employees
IPO DateJul 14, 2000
CountryUS
Actively Trading

Frequently Asked Questions